Pharmaceutical company Zylo Therapeutics is opening in Greenville at the Next on Main facility at 101 North Main St., and is expected to create 30 jobs.
Zylo Therapeutics has developed an innovative sustained-release drug-delivery system that delivers traditionally hard-to-deliver therapeutic agents through topical administration. With more than 10 years of research and development, the technology continues to improve, providing 24-hour sustained release of a variety of agents, including nitric oxide, curcumin, and lidocaine, according to the S.C. Department of Commerce.
"With the bulk of our scientists and advisers located in the Northeast corridor, we considered a variety of alternative locations, but Greenville represents a wonderful balance of small-town feel, sophistication, high growth and vibrancy,” said Zylo Therapeutics CEO Scott Pancoast, in a news release. “In addition, the city offers a wealth of startup resources that will assuredly work to our advantage over time."
Zylo Therapeutics' operations will include a lab facility, where formulation and product development work will be performed.
"We are excited to welcome Zylo Therapeutics as the newest member of Next and the Greenville startup community. This high-impact, knowledge-based company further strengthens the more than 150 companies within this vibrant, entrepreneurial ecosystem," said Next CEO John Moore, in the release. Next is a program of the Greenville Chamber of Commerce that supports knowledge-based companies in Upstate.